CIK 0001736730
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Camp4 Therapeutics Corp
Sign in to watch- Ticker
- CAMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-651-8867
- Business address
- 100 TALCOTT AVENUE, SUITE 201, WATERTOWN, MA, 02472
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 2,941,176 shares (grant or award)
- 4 Open-market buy 10% owner bought 2,941,176 shares at $1.53 ($4,499,999)
- 4 Open-market buy 10% owner bought 1,307,189 shares at $1.53 ($1,999,999)
- 4 Open-market buy Director bought 1,307,189 shares at $1.53 ($1,999,999)
- 4 Open-market buy Chief Medical Officer bought 6,060 shares at $1.65 ($9,999)
- 4 Open-market buy Chief Financial Officer bought 6,060 shares at $1.65 ($9,999)
- 4 Open-market buy Chief Executive Officer bought 6,060 shares at $1.65 ($9,999)
- 4 Open-market buy Director bought 15,151 shares at $1.65 ($24,999)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 5 · 84 filings